This report provides a comprehensive overview of the latest studies on EPA and DHA omega-3s and their effects on attention-deficit hyperactive disorder (ADHD). It was created with the help of GOED’s Clinical Study Database (CSD), a powerful tool developed and maintained by GOED to compile and organize more than 4,500 human clinical studies related to EPA and DHA omega-3s. 

Buy now to get valuable insights into the current state of omega-3 and ADHD science, identify research gaps and explore potential directions for future projects or product innovations. The report answers the question, "What does the body of evidence around EPA+DHA supplementation and ADHD in human clinical trials show?"

To learn more about the CSD — and how we saved approximately 30 hours of work putting this report together compared to employing a traditional academic search strategy — click here.

Team members of GOED member companies can log into their GOED Dashboard accounts and visit this page to access the report for free.

Researchers who don't work at GOED member companies can buy the report for US$199 below.

GOED members, please log in to see a discounted total for this item in your cart.